One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1093/annonc/mdy279.406
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2018 |
 Citations: 7 |  License type: publisher-specific-oa |
Affiliation: National Cancer Institute, ECOG-ACRIN Cancer Research Group, Frederick National Laboratory for Cancer Research, Center for Cancer Research, Southwestern Medical Center, The University of Texas Southwestern Medical Center, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, TherapeuticsMD (United States), Massachusetts General Hospital, Sidney Kimmel Cancer Center, Thomas Jefferson University, University of Pittsburgh Medical Center418PD - NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
